{
    "code": "02024130",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024130",
    "time": "2020-02-25 13:17:33",
    "許可證字號": "衛署藥輸字第024130號",
    "註銷狀態": "已註銷",
    "註銷日期": "104\/06\/01",
    "註銷理由": "自請註銷",
    "有效日期": "103\/12\/02",
    "發證日期": "93\/12\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202413002",
    "中文品名": "艾來迪持續性藥效錠",
    "英文品名": "ALLEGRA-D 12 HOUR EXTENDED-RELEASE TABLETS",
    "適應症": "緩解成人及十二歲以上的孩童因罹患季節性過敏性鼻炎所導致之相關症狀。",
    "劑型": "121持續性藥效錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 54依本署89、12、12衛署藥字第0890035812號公告事項九得免除國內進行臨床試驗之特殊醫療需要之新藥",
        "申請商名稱": "1424601100  賽諾菲股份有限公司",
        "申請商地址": "台北市松山區復興北路337號12、13、14樓",
        "主製造廠": ""
    },
    "CCC號列": "30049099101 抗過敏抗組織胺用藥Drugs for antihypersensitivity and antihistamine",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400006110",
            "成分名稱": "FEXOFENADINE HYDROCHLORIDE",
            "含量描述": "",
            "含量": "60.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1212002610",
            "成分名稱": "PSEUDOEPHEDRINE HCL",
            "含量描述": "",
            "含量": "120.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色\/淡黃橙",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "長圓柱形",
        "標記一": "allegra-D",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "02024130.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024130&Seq=438&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "020241300004.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024130&Seq=007&Type=9"
        }
    ]
}